title: American Society of Hematology--44th Annual Meeting and Exposition. Drug highlights II. 6-10 December 2002, Philadelphia, PA, USA.
authors.affiliation: Thomson Current Drugs, Middlesex House, 34-42 Cleveland Street, London W1T 4LB, UK. melanie.adekale@current-drugs.com
authors.forename: Melanie
authors.initials: M
authors.lastname: Adekale
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015316:Genetic Therapy; D005914:Globins / Q000235:genetics; D006402:Hematologic Diseases / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008565:Membrane Proteins / Q000037:antagonists & inhibitors; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D009930:Organic Chemicals; D019098:Telomerase / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D008565:Membrane Proteins; D009930:Organic Chemicals; C084881:flt3 ligand protein; C113282:prinomastat; D005914:Globins; D019098:Telomerase; D008666:Metalloendopeptidases